mason from eli lilly who is making a profit from these increases in insulin prices. i think you, 1st of all, we don't want anyone not to bill for der insulin who is making a profit with is increases in insulin prices that patients have to pay for our net prices. the parts that we receive are going down, are you, are you making a profit or the ceo's of your company's making? these profits are our net prices. the price we receive has gone down to 2009. well, somebody is making a profit, somebody's getting richer on the backs of our patients. a mr. lambda from nova, nor disk. what entity in this supply chain is prioritizing affordability and access of insulin for patients. or we like to think we are, i mean we, we participated as many formulas as we can, as i've mentioned that is critically most important. we have patient systems, assistant programs as well as co pay system, provo who is making a profit thing. well our nets, her going down as well, but there is a small profit that your nets but your overall, your overall profits for the company and ceo's have been going